- Knowledge center
Mieke van Acker joined as CEO in November 2019 to lead Biogazelle into its next growth phase. An experienced business leader, she has held a series of executive positions at Merck Millipore over the years, including VP Head of Global Sales BioScience and VP Head of Strategy and Business Development Lab Solutions. Most recently she has been co-CEO of Belgian startup MyCartis. Mieke holds Master's degrees in Biochemistry and Business Economics from KULeuven and is an alumnus of the Advanced Management Programme from INSEAD.
Jan Hellemans is one of the founders of Biogazelle. Jan has a Master's degree in Biotechnology, a PhD in Medical Sciences (Ghent University, Belgium) and over 15 years of experience in human genetics. He acquired extensive experience in next generation sequencing and genetic diagnostics from managing an academic core facility and introducing the corresponding wet and dry lab technology in a clinical diagnostics lab at Ghent University Hospital.
Jo Vandesompele has a Master's degree in Bio-engineering and a PhD in Medical Sciences. As Chief Scientific Officer, he is responsible for the scientific progress in the company. Jo also holds a professorship at Ghent University, studying non-coding RNA biology in cancer and developing nucleic acid quantification strategies. He is co-author of more than 200 peer-reviewed articles, together cited more than 30,000 times.
Alexander Baumann is responsible for the development and execution of Biogazelle’s sales & marketing strategy. He joined Biogazelle in April 2019 with 14 years of sales & business development experience in the outsourcing market, supporting drug discovery and development. He has a PhD in Molecular Biology (Freiburg University, Germany). Most recently Alexander was Regional Head of Sales at Eurofins Pharma Discovery Services and prior to that, he served as Director of Sales & Technical Support at Discoverx.